Cardiology
-
Kolling researcher among hypertension thought leaders at international meeting
Posted on:
Kolling Institute researcher and RNSH Senior Hospital Scientist Dr Anastasia Mihailidou says she was delighted to showcase the district’s work in blood pressure management on the world stage. Dr Mihailidou, who is head of the Kolling’s Cardiovascular and Hormonal Research Lab, presented at the recent International Society of Hypertension Scientific Meeting in Japan. Globally renowned
-
Our research expertise recognised with multi-million dollar grants
Posted on:
We would like to congratulate Professors Carol Pollock and Gemma Figtree who have received significant National Health and Medical Research Council Investigator Grants. Despite a tremendously competitive field, both clinician/researchers have been awarded $2 million to progress their world-leading research and improve long-term patient outcomes. The announcement highlights the experience and expertise at the Kolling
-
Researchers to study link between cardiovascular disease and sleep apnoea
Posted on:
With a disturbing number of people losing their lives to heart disease each year, researchers have launched the first study of its kind using MRI technology to broaden our understanding of the link between cardiovascular disease and sleep apnoea. The project has been made possible following funding from the Ramsay Research Grant Program, and will
-
Masters players committed to the team, ignore heart health
Posted on:
Research from the University of Sydney and Royal North Shore Hospital provides insights into cardiac risk among footballers of masters age (35 years and older), an increasingly popular pastime. In what is believed to be the first study to assess cardiac knowledge and beliefs in this higher-risk amateur football group, researchers have found that one
-
Study confirms deadly risk of COVID-19 for those with heart failure
Posted on:
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed
-
New test for high blood pressure to save lives
Posted on:
Researchers and clinicians have welcomed Federal Government funding to improve the diagnosis and treatment of high blood pressure. The condition affects around 1 in 3 people in Australia, significantly increasing the risk of stroke, coronary heart disease, heart failure and chronic kidney disease. Men are more likely to have uncontrolled high blood pressure, with 1
-
Life after cardiac arrest
Posted on:
Just over two years ago, Ian Hutchinson (Hutch) was cycling with a friend on Sydney’s northern beaches, taking part in an activity he regularly enjoyed with his mate. But that morning was to have a life-changing impact, with Hutch suffering a sudden cardiac arrest midway through the ride. It was only the quick thinking of
Category:
-
Kolling researchers identifying COVID-19 impact on heart health
Posted on:
The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125
-
Kolling researchers join global effort to reduce heart disease in women
Posted on:
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The Lancet women
Category:
-
Researchers drive global call to action to tackle world’s leading cause of death
Posted on:
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died
Category:
Copyright © 2026 Kolling Institute
All rights reserved